{"Drugs":{"Drug":{"Id":41962,"DrugType":{"Type":"Small molecule therapeutic"},"DrugTargetMaturity":{"TargetIndication":{"IndicationId":152,"IndicationName":"Hepatitis B virus infection","MinPatentApplicationDate":"1983-08-18T00:00:00Z","TargetId":"PTGT-00626","TargetName":"DNA polymerase"}},"DevelopmentStatusCurrent":{"Row":[{"Company":{"@id":"17101","$":"Il Dong Pharmaceutical Co Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2017-11-01T00:00:00Z","SourceLink":{"@type":"OTHER","@id":"1995095"}},{"Company":{"@id":"27894","$":"Anadys Pharmaceuticals Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2007-08-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"818218"}},{"Company":{"@id":"30057","$":"LG Life Sciences Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"OL","@sortorder":"1","$":"Outlicensed"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2012-10-01T00:00:00Z","SourceLink":{"@type":"SERIAL","@id":"1351977"}}]},"DevelopmentStatusHistoric":{"Row":[{"Company":{"@id":"17101","$":"Il Dong Pharmaceutical Co Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2017-05-15T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1939606"}},{"Company":{"@id":"17101","$":"Il Dong Pharmaceutical Co Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2016-09-26T00:00:00Z","SourceLink":{"@type":"PR","@id":"1801311"}},{"Company":{"@id":"17101","$":"Il Dong Pharmaceutical Co Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"C3","@sortorder":"12","$":"Phase 3 Clinical"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2013-10-31T00:00:00Z","SourceLink":{"@type":"TRIALREG","@id":"1485478"}},{"Company":{"@id":"27894","$":"Anadys Pharmaceuticals Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2004-04-19T00:00:00Z","SourceLink":{"@type":"PR","@id":"533708"}},{"Company":{"@id":"17101","$":"Il Dong Pharmaceutical Co Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2012-10-01T00:00:00Z","SourceLink":{"@type":"SERIAL","@id":"1351977"}},{"Company":{"@id":"30057","$":"LG Life Sciences Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2003-04-13T00:00:00Z","SourceLink":{"@type":"SERIAL","@id":"490551"}},{"Company":{"@id":"22235","$":"LG Chem Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2002-10-07T00:00:00Z","SourceLink":{"@type":"SERIAL","@id":"464777"}},{"Company":{"@id":"30057","$":"LG Life Sciences Ltd"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"152","$":"Hepatitis B virus infection"},"StatusDate":"2002-10-31T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"504415"}}]}}}}